Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIVISE Map Concordance Study in DBS for Parkinson's Disease

NCT01750242 is registered in ClinicalTrials.gov with MedtronicNeuro as lead sponsor.

NCT NCT01750242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01750242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIVISE Map Concordance Study in DBS for Parkinson's Disease
Lead sponsor
MedtronicNeuro
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
August 31, 2013
Enrollment
20 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease